FDA Adverse Event Death Summary report: N

EUFLEXXA 20MG/2ML (6=3 SYR)

MDR report key: 17001773 · Received May 24, 2023

Report

Report Number
MW5117809
Event Type
Death
Date Received
May 24, 2023
Date of Event
December 16, 2022
Report Date
May 22, 2023
Manufacturer
FERRING PHARMACEUTICALS, INC.
Product Code
MOZ
UDI-DI
55566410001
Adverse Event
Yes
Report Source
Voluntary report
Reporter Location
PA, US
Reporter Occupation
PHARMACIST
Health Professional
Yes

Narratives

Description of Event or Problem · 0

THE PT'S DAUGHTER REPORTS THE PT PASSED AWAY ON (B)(6) 2022. INJECT 1 SYRINGE INTO BILATERAL KNEES ONCE A WEEK FOR 3 WEEKS. PRESCRIBER INFO: (B)(6). REF REPORTS: MW5117808, MW5117810.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1618185 EUFLEXXA 20MG/2ML (6=3 SYR) ACID, HYALURONIC, INTRAARTICULAR MOZ FERRING PHARMACEUTICALS, INC. U10185A 55566410001

Patients

Seq Age Sex Outcome Treatment
1 89 YR Female Death